Ghent-based healthtech startup Cavell has secured €1.5 million in a pre-seed funding round to enhance the accuracy and reliability of medical data. The investors involved in this round have not been publicly disclosed.
- Established in 2024 by Anthony Rathé, Pieter Olivier, and Louis Verdonckt, Cavell develops AI-powered software that tackles administrative overload and poor medical data quality in healthcare.
- Cavell’s solution listens during consultations, surgeries, or nurse rounds and automatically generates structured, high-quality medical documentation, such as consultation notes, referral letters, and hospitalization reports, in less than 60 seconds.
- It also extracts relevant clinical codes (e.g., SNOMED-CT) and translates complex medical language into patient-friendly summaries. All data is stored locally on the user’s device, audio recordings are never retained, and the system is fully GDPR-compliant.
"Several promising partnerships are in the pipeline to bring Cavell to many healthcare providers in Belgium. But our ambition goes beyond Belgium, we want to improve healthcare across Europe. We’re incredibly excited to keep building a care system that truly revolves around the patient," explains Louis Verdonckt, co-founder of Cavell.
- Cavell will use the €1.5 million to accelerate the development of its AI-driven medical documentation platform, expand operations in Belgium and Europe, and ensure seamless integration with existing healthcare systems.
- The funding will also support strategic partnerships and enhance the platform's usability for healthcare professionals, advancing Cavell’s mission to improve efficiency and patient-centred care.
"Our goal isn’t just to be a digital health tool. We’re building technology that truly works for people in healthcare — robust, user-friendly, and integrated. Only then can we make a lasting difference," co-founder of Cavell, Anthony Rathé, commented.
